Spring Works Therapeutics (SWTX) PT Raised to $75 at JPMorgan
Tweet
Share
E-mailGet Alerts SWTX Hot Sheet
Price: $46.99 --0%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Spring Works Therapeutics (NASDAQ: SWTX) to $75.00 (from $74.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$440 at Macquarie
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
